By taking conventionalist view of the evolution of biotechnology, we suggest that the process
by which entrepreneurs determined what made biotechnology valuable and figured out how …

The motivation (and personal ex-ante assumption) for this chapter comes from our combined
20 years' experience of research, consulting, operational positions, and ownership of more …

Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience
relates the intensifying effort of bioentrepreneurs to apply genetic engineering technologies …

This book is aimed at providing a large audience, including practitioners, politicians and
decision-makers, with useful insights in relation to innovation and entrepreneurship in the …

This special issue explores cases from Latin American countries, studied in comparison to
global trends in the arenas of public participation, scientific knowledge production …

All would agree that with more than 3,000 new firms formed in Europe, Japan and the United
States focused on biotechnology, and with elegant strides forward in our understanding of …

Over the past three decades, the biotechnology industry has emerged as a vital and
dynamic source of new technologies for the pharmaceutical and agricultural chemical …

Where do new practices and models of organization come from? of course, nothing is
entirely new, so the obvious answer is that new things trace their lineages back through …

Biotechnology and Competitive Advantage investigates the development of biotechnology in
Europe and the United States. It examines why Europe has fallen behind in applying …

This case describes Anne Evans' search for a market opportunity in the biotechnology
industry, and examines the feasibility of establishing a new venture to exploit this …